BRAF and cutaneous melanoma: Most cutaneous melanomas show an aberrant activation of the mitogen-activated protein kinase (MAPK) pathway and mutations in proteins along the RAS-RAF-MEK-ERK pathway: 50% B-RAF-mutated and 15% NRAS-mutated [3].